THNR Overview

Profile

Name:

Amplify Weight Loss Drug & Treatment ETF

Assets under management:

$3 M

Expense ratio:

0.59%

Inception date:

-

Website:

-

Last ex-dividend date:

December 30, 2024

Next ex-dividend date:

N/A

Description:

THNR ETF is an exchange-traded fund that focuses on companies involved in renewable energy and sustainable practices. It aims to provide investors with exposure to the growing green economy while promoting environmental sustainability. The fund is designed for those looking to invest in eco-friendly businesses.

Top holdings

Name
Weight
12.86 %
Roche Holding AG(ROG.SW)
5.93 %
5.85 %
AMGN logo
Amgen(AMGN)
5.77 %
Chugai Pharmaceutical Co Ltd(4519.T)
5.75 %
PFE logo
Pfizer(PFE)
5.35 %
4.68 %
FUJIFILM Holdings Corp(4901.T)
3.94 %
Innovent Biologics Inc(1801.HK)
3.50 %
Merck KGaA(MRK.DE)
3.36 %
MITSUBISHI CHEMICAL GROUP CORP(4188.T)
2.91 %
Zealand Pharma A/S(ZEAL.CO)
2.64 %
1.47 %
Gerresheimer AG(GXI.DE)
0.51 %
Hanmi Pharm Co Ltd(128940.KS)
0.45 %
Bachem Holding AG(BANB.SW)
0.38 %
United Laboratories International Holdings Ltd/The(3933.HK)
0.32 %
Invesco Government & Agency Portfolio 12/31/2031(AGPXX)
0.27 %
Ypsomed Holding AG(YPSN.SW)
0.26 %
0.25 %
Cash & Other(Cash&Other)
0.24 %
0.21 %
Gubra A/S(GUBRA.CO)
0.07 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Dividend yield

Top holdings

Name
Weight
12.86 %
Roche Holding AG(ROG.SW)
5.93 %
5.85 %
AMGN logo
Amgen(AMGN)
5.77 %
Chugai Pharmaceutical Co Ltd(4519.T)
5.75 %
PFE logo
Pfizer(PFE)
5.35 %
4.68 %
FUJIFILM Holdings Corp(4901.T)
3.94 %
Innovent Biologics Inc(1801.HK)
3.50 %
Merck KGaA(MRK.DE)
3.36 %
MITSUBISHI CHEMICAL GROUP CORP(4188.T)
2.91 %
Zealand Pharma A/S(ZEAL.CO)
2.64 %
1.47 %
Gerresheimer AG(GXI.DE)
0.51 %
Hanmi Pharm Co Ltd(128940.KS)
0.45 %
Bachem Holding AG(BANB.SW)
0.38 %
United Laboratories International Holdings Ltd/The(3933.HK)
0.32 %
Invesco Government & Agency Portfolio 12/31/2031(AGPXX)
0.27 %
Ypsomed Holding AG(YPSN.SW)
0.26 %
0.25 %
Cash & Other(Cash&Other)
0.24 %
0.21 %
Gubra A/S(GUBRA.CO)
0.07 %

Analyst ratings

FAQ

  • What is THNR?
  • Does THNR pay dividends?
  • What stocks are in THNR?
  • What is the current assets under management for THNR?
  • What is THNR average volume?
  • What is THNR expense ratio?
  • What is THNR inception date?

What is THNR?

THNR ETF is an exchange-traded fund that focuses on companies involved in renewable energy and sustainable practices. It aims to provide investors with exposure to the growing green economy while promoting environmental sustainability. The fund is designed for those looking to invest in eco-friendly businesses.

Does THNR pay dividends?

Yes, the Amplify Weight Loss Drug & Treatment ETF does pays dividends, with the most recent payment being $0.22 per share. The last ex-dividend date was on December 30, 2024, and the next ex-dividend date has not been announced yet

What stocks are in THNR?

As of today, Amplify Weight Loss Drug & Treatment ETF inlcudes 30 holdings, with 15 of them being companies from 8 different countries and 2 sectors. The most weighted holdings are Eli Lilly and Company (18.13%), Novo Nordisk A/S (12.86%) and Roche Holding AG (5.93%)

What is the current assets under management for THNR?

Assets under management of Amplify Weight Loss Drug & Treatment ETF is $3 M

What is THNR average volume?

Average volume of Amplify Weight Loss Drug & Treatment ETF is $7357

What is THNR expense ratio?

Expense ratio of Amplify Weight Loss Drug & Treatment ETF is 0.59%

What is THNR inception date?

null